NIH awards $3.4 million to support research on Crimean-Congo hemorrhagic fever virus
Crimean-Congo hemorrhagic fever virus, or CCHFV, is a biosafety level 4 pathogen and a Category A bioterrorism agent,…
New microfluidic-based biosensing platform helps track live antibody secretion dynamics
A research team at the Terasaki Institute, led by Dr. Vadim Jucaud in collaboration with Dr. Jing Yong…
New NIH grant supports development of experimental pediatric HIV vaccine
A multi-institutional team led by Weill Cornell Medicine investigators has been awarded a five-year, $20.8 million grant from…
Early B cell response prevents Oropouche virus from reaching the brain
Research conducted on mice has identified that the rapid response of a specific type of defense cell is…
Waning Japanese encephalitis immunity linked to more severe dengue illness
Scientists from Duke-NUS Medical School, in collaboration with researchers in Nepal, have found that waning immunity to Japanese…
Antibody cocktail could change the way the world fights influenza
An unusual therapy developed at The Jackson Laboratory (JAX) could change the way the world fights influenza, one…